Section
Data
Original data analysis and drug pricing intelligence
Data
Aetna just dropped Eliquis from its 2026 preferred formulary. This move puts $13B in US sales at risk and scra…
Data
With Amgen’s ABP 959 biosimilar set to contest Soliris, PNH market share could swing by billions. Here’s what …
Data
This quarter’s NADAC update shows ADHD stimulants up 18% and metformin generics down 13%. Here’s how the lates…
Data
New HRSA data reveals contract pharmacy 340B claims grew 22% last year. Manufacturers and covered entities are…
Data
The FDA shortage list hit a 10-year high. Oncology sterile injectables are the worst affected category.…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.